-The excitatory neurotransmitter glutamate causes dilation of newborn pig cerebral arterioles in vivo that is blocked by inhibition of carbon monoxide (CO) production. CO, a potent dilator in cerebral circulation in vivo, is produced endogenously in cerebral microvessels via heme oxygenase (HO). In isolated pressurized cerebral arterioles (ϳ200 m) from newborn pigs, we investigated the involvement of CO and the endothelium in response to glutamate. A CO-releasing molecule, dimanganese decacarbonyl (10 Ϫ8 -10 Ϫ6 M), dilated cerebral arterioles. Glutamate (10 Ϫ6 -10 Ϫ4 M) and 1-aminocyclopentane-cis-1,3-dicarboxylic acid (cis-ACPD; 10 Ϫ6 -10 Ϫ5 M), a N-methyl-D-aspartate (NMDA) receptor agonist, caused cerebral vascular dilation. Dilation of cerebral arterioles to glutamate and cis-ACPD was abolished by chromium mesoporphyrin (CrMP; 10 Ϫ6 M), a HO inhibitor. In contrast, CrMP did not alter dilation to isoproterenol, a ␤-adrenergic receptor agonist. Endothelium-denuded cerebral arterioles did not dilate to glutamate or bradykinin (endothelium-dependent dilator), whereas responses to isoproterenol were preserved. These data indicate that cerebral arterioles from newborn pigs may directly respond to glutamate and the NMDA receptor agonists by endothelium-dependent dilation that involves stimulation of CO production via the HO pathway in the endothelium. heme oxygenase; endothelial L-GLUTAMIC ACID (glutamate) is the principal excitatory neurotransmitter in the central nervous system (20) . In the cerebral circulation in vivo, glutamate is a vasodilator (4, 8, 9, 27) . Glutamate may exert its effects via different types of receptors, including N-methyl-D-aspartate (NMDA), ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), and kainate-type ionotropic glutamate receptors (10) . Our data in vivo indicate that carbon monoxide (CO) is essential for the vasodilator effects of glutamate in the newborn pig cerebral circulation (17) . CO is a potent vasodilator in the cerebral circulation of newborn pigs and plays an important role in maintaining cerebral vascular tone (17, 18) . Heme oxygenase (HO) is the enzyme that produces CO from the catabolism of heme (19) . Three different isoforms of HO have been identified: the easily inducible HO-1; the constitutively expressed, poorly inducible HO-2; and an isoform with much lower heme-degrading activity, . Both vascular endothelium and smooth muscle cells express HO-1 and HO-2 (5, 26, 34) . HO-2 is expressed in high concentration in the brain and in cerebral microvessels (1, 18, 19, 26) . Recently, we (27) demonstrated that glutamate and agonists of NMDA and AMPA/kainate-type glutamate receptors cause dose-dependent vasodilation of newborn pig pial arterioles that is blocked by HO inhibitors.
Cerebral microvessels and, specifically, cerebral microvascular endothelial cells express glutamate receptors. Krizbai et al. (16) reported the presence of glutamate receptors in cultured cerebral endothelial cells isolated from the rat brain. We (25, 26) recently detected high-affinity glutamate receptors in cerebral microvascular endothelial cells of newborn pigs in primary culture. Additionally, glutamate stimulates HO activity and increases CO production in freshly isolated cerebral microvessels in vitro (25, 27) . These data indicate that, in addition to neuronal-mediated influences, cerebral microvessels may also respond directly to glutamate.
The present study was designed to investigate whether cerebral arterioles, removed from the brain, respond to glutamate by changing vascular tone via an endothelium-dependent and CO-mediated mechanism.
METHODS
The animal protocols used were reviewed and approved by the Animal Care and Use Committee of the University of Tennessee Health Science Center.
Pressurized cerebral arterioles. Newborn pigs (1-5 days old) of either sex were anesthetized with ketamine hydrochloride (33 mg/kg im) and acepromazine (3.3 mg/kg im). The brain was removed and placed into a physiological saline solution (in mM: 132 NaCl, 3 KCl, 24.6 NaHCO 3, 1.8 CaCl2, 1.5 MgCl2, and 10 glucose) at 4°C. Arteriolar branches of the middle cerebral artery (ϳ200 m in diameter) were dissected from the brain and cleaned of connective tissue. An arteriolar segment was placed in a temperature-controlled perfusion chamber and cannulated with glass pipettes at each end. The bathing chamber was continuously superfused at 3-6 ml/min with physiological solution equilibrated with a mixture of 6% CO 2-6% O2-88% N2 to pH 7.4 and maintained at 37°C. Arterioles were observed with a charge-coupled device (CCD) camera coupled to an inverted microscope (Nikon TS 100-F). Arteriolar diameter was continuously monitored using the automatic edge-detection function of IonWizard software (IonOptix; Milton, MA).
Cerebral arterioles were pressurized to 10 mmHg, and, after a 10-min equilibration period, intraluminal pressure was increased to 30 mmHg. Typically, an elevation in intraluminal pressure resulted in an immediate increase in the diameter of the arteriole, followed by myogenic constriction. After 40-50 min of stabilization, tested compounds (glutamate, glutamate receptor agonist, or CO-releasing molecule) were applied in increasing concentrations. The variation of the internal diameter in the single isolated vessel was continuously measured and recorded by videomicroscopy. The maximal steady-state diameter attained over a 10-min period was recorded as the response to each dose. At the end of each tested response, the vessel was superfused with physiological solution to remove the previous stimulus and allow the arteriole to return to the baseline diameter.
In a separate set of experiments, arterioles were denuded of endothelium using a pipette introduced into the lumen. The effectiveness of denudation was confirmed by the absence of the dilatory response to bradykinin (10 Ϫ5 M), an endothelium-dependent cerebral vasodilator (33) . The response to an endothelium-independent vasodilator, the ␤-adrenoreceptor agonist isoproterenol (10 Ϫ6 M), was tested to verify that vascular smooth muscle integrity was preserved.
To investigate the involvement of HO in cerebral arteriolar dilations induced by glutamate and glutamate receptor agonists, the arterioles were superfused with a HO inhibitor, chromium mesoporphyrin (CrMP; 10 Ϫ6 M). Nimodipine (10 Ϫ6 M), a voltage-dependent calcium channel blocker, was applied at the end of the experiment to determine the passive arteriolar diameter.
HO-2 immunofluorescence in cerebral microvascular endothelial cells. To identify HO-2, the constitutive isoform of HO, in cerebral vascular endothelium, we used primary cultures of endothelial cells from cerebral microvessels (60-300 m) of newborn pigs. Isolation of cerebral microvessels and endothelial cells has been described previously (26) . Endothelial cells from cerebral microvessels were plated on Matrigelcovered glass coverslips and cultured in DMEM with 20% FBS, 30 g/ml endothelial cell growth supplement, 1 U/ml heparin, and an antibiotic/antimycotic mixture for 5-6 days until confluence. Cells were exposed to a serum-depleted medium (0.1% FBS) for 15-20 h before the immunostaining to achieve quiescence. Cells were fixed with 3.7% paraformaldehyde in PBS (pH 8.4) (15 min, room temperature) and permeabilized by 0.1% Triton X-100 solution in PBS (10 min, room temperature). The nonspecific binding sites were blocked by 5% BSA (1 h at room temperature). Cells were incubated with the anti-HO-2 polyclonal antibody (dilution 1:50, StressGen; Victoria, Canada) for 1 h at 37°C followed by FITC-conjugated anti-rabbit IgG (dilution 1:100, Vector Laboratories; Burlingame, CA) for 1 h at 37°C (26) . Coverslips were mounted on glass slides using antifade mounting medium (Vector Laboratories). Slides were viewed by a Nikon Diaphot microscope in conjunction with a cooled CCD camera (Photometric model 250 CH) and processed using an Image Deconvolution system. Three consequent images taken from each slide were deconvolved using Vaytech software for deconvolution and IPLab Spectrum software for image collection. For negative controls, cells were incubated with secondary antibody only and processed further as described above. Negative controls showed no immunofluorescence.
Materials. Glutamate, isoproterenol, bradykinin, and nimodipine were purchased from Sigma (St. Louis, MO). 1-Aminocyclopentane-cis-1,3-dicarboxylic acid (cis-ACPD), a NMDA receptor agonist, was purchased from Tocris (Ellisville, MO). Dimanganese decacarbonyl (DMDC; Sigma) was dissolved in DMSO and then stored under nitrogen at 0°C. The release of CO from the carbonyl metal complex is induced by photodissociation (24) . Therefore, the compound was protected from light during storage and delivery to the chamber. Photodissociation was induced in the chamber by the microscope light. CrMP was purchased from Porphyrin Products (Logan, UT). CrMP and nimodipine were protected from light at all times, and the chamber was illuminated only during arteriolar diameter measurements. Cell culture reagents were purchased from Sigma, Life Technologies (Gaithersburg, MD), Becton Dickinson (Bedford, MA), and Hy-Clone (Logan, UT).
Data analysis. Values are presented as means Ϯ SE. Data were analyzed by ANOVA with Fisher's protected leastsignificant-difference test to compare two individual groups. A level of P Ͻ 0.05 was considered statistically significant.
RESULTS

Vasoactive effects of the CO-releasing molecule and HO inhibition.
To investigate whether CO dilates isolated cerebral arterioles, we used DMDC, a CO-releasing molecule (24) . Pressurized cerebral arterioles of newborn pigs were superfused with DMDC at concentrations between 10 Ϫ8 and 10 Ϫ6 M, and CO release by photodissociation was induced in the perfusion chamber by the microscope light. DMDC dilated isolated cerebral arterioles in a concentration-dependent manner ( Figs. 1 and 2) . To investigate the contribution of CO produced endogenously by HO to vascular tone, the arterioles were exposed to a HO inhibitor, CrMP. CrMP effectively inhibits HO activity in cerebral microvascular endothelial cells (26) and blocks HO-mediated cerebral vascular responses in newborn pigs in vivo (17) . CrMP (10 Ϫ6 M) caused constriction of pressurized arterioles (percent change compared with the basal diameter: Ϫ13 Ϯ 4, P Ͻ 0.05), suggesting a possible contribution of endogenously produced CO to basal vascular tone.
Vasoactive effects of glutamate on intact cerebral arterioles. We investigated whether glutamate regulates tone in isolated cerebral arterioles. After development of myogenic tone, cerebral arterioles were superfused with progressively increasing concentrations of glutamate (10 Ϫ6 -10 Ϫ3 M). Glutamate induced concentration-dependent dilation of cerebral arterioles, with the maximum vasodilation at 10 Ϫ4 M (Figs. 3 and  4) . In arterioles pretreated with CrMP (10 Ϫ6 M), vasodilator responses to glutamate were blocked (Figs. 4  and 5 ). Similar to glutamate, cis-ACPD, a potent NMDA receptor agonist, at concentrations of 10 Ϫ6 and 10 Ϫ5 M, caused cerebral vasodilation that was completely inhibited by CrMP (Fig. 6) . In contrast, CrMP did not alter the dilation to cAMP-dependent isoproterenol (10 Ϫ6 M), suggesting that CrMP does not non-selectivity inhibit CO-independent changes in vascular reactivity (Fig. 7) .
Vasoactive effects of glutamate in endothelium-denuded cerebral arterioles. The importance of the endothelium for vasodilation to glutamate was investigated in endothelium-denuded arterioles. To test the effectiveness of denudation, vascular responses to bradykinin (10 Ϫ5 M), an endothelium-dependent vasodilator (33), and to isoproterenol (10 Ϫ6 M), an endotheliumindependent vasodilator, were examined. Glutamate (10 Ϫ6 and 10 Ϫ5 M) and bradykinin (10 Ϫ5 M) induced vasodilation in endothelium-intact cerebral arterioles and caused vasoconstriction in endothelium-denuded arterioles (Fig. 8) . In contrast, isoproterenol induced vasodilation in both endothelium-intact and -denuded arterioles (Fig. 8) . These data suggest that in isolated cerebral arterioles, glutamate and bradykinin are endothelium-dependent vasodilators, and isoproterenol dilates in the absence of intact endothelium.
HO-2 immunostaining in cerebral vascular endothelium.
Our data demonstrate the importance of the endothelium and HO activity in dilation responses of isolated cerebral microvessels to glutamate. HO-2 is the constitutive isoform of HO, is highly expressed in isolated cerebral microvessels of newborn pigs, and produces CO from cellular heme (17, 27) . Therefore, we examined cerebral microvascular endothelial cells to confirm the presence of HO-2. HO-2 was detected in vascular endothelial cells from cerebral microvessels (60-300 m) by indirect fluorescent immunostaining using selective antibodies (Fig. 9) . In endothelial cells, HO-2 is localized in the perinuclear area of the cytoplasm (the endoplasmic reticulum area) and in the nuclear envelope (Fig. 9) , confirming our previous findings (26) . 
DISCUSSION
The novel findings of this study in isolated pressurized cerebral arterioles from newborn pigs are as follows: 1) DMDC, a CO-releasing molecule, dilates isolated cerebral arterioles; 2) glutamate and an NMDA receptor agonist, cis-ACPD, dilate isolated cerebral arterioles; 3) glutamatergic vasodilation is blocked by HO inhibition; and 4) glutamate is an endothelium-dependent vasodilator in isolated cerebral arterioles.
CO is a vasodilator in vivo (15, 17, 30) . Endogenous CO can play an important role in the regulation of vascular tone. HO inhibition causes hypertension in normotensive rats, and intravenous administration of the HO substrate reduces blood pressure in hypertensive rats (13, 14) . In isolated pressurized rat gracilis muscle arterioles, superfusion with CrMP, a HO inhibitor, decreased arteriolar diameter (15) . In the present study, we also found that CrMP at a concentration that blocks HO activity in cerebral microcirculation in vitro [10 Ϫ6 M (26)], constricted isolated cerebral arterioles form newborn pigs. In isolated rat tail arterioles, CO caused dose-dependent vasodilation (15, 30) . In vivo, cerebral arterioles of newborn pigs respond to CO with vasodilation that is dose dependent (17) . Initially, the vasodilator effects of CO were attributed to a direct action on vascular smooth muscle cells by a cGMPmediated relaxing mechanism (5, 7, 11, 22, 30) . How- Fig. 4 . Original trace showing the effects of glutamate, bradykinin (BK), and Iso on the internal diameter of a pressurized cerebral arteriole from a newborn pig in the absence and presence of chromium mesoporphyrin (CrMP), a heme oxygenase (HO) inhibitor. Because of the light sensitivity of CrMP, the arteriolar diameter was measured only at the time points indicated (microscope light off, dotted line). ever, CO can cause vasodilation independently of cGMP by causing smooth muscle hyperpolarization via activation of calcium-activated potassium channels (11, 12, 17, 29, 31, 32) . In the isolated rat tail artery, both mechanisms can be involved in CO-induced relaxation (30) (31) (32) .
A previous attempt to demonstrate dilation of isolated cerebral arterioles in response to CO was not successful (3). Failure to detect dilation of isolated arterioles may be because gaseous CO is difficult to maintain at intended concentrations in solutions exposed to air (30) . To circumvent this problem, we superfused isolated pressurized cerebral arterioles with a molecule that releases CO on exposure to light (24) . In our experiments, the CO-releasing molecule, DMDC, caused a concentration-dependent vasodilation, which is similar to that observed when pial arterioles were exposed to CO under a closed cranial window in vivo (17) .
Glutamate is a major excitatory neurotransmitter in the brain. In the cerebral microcirculation of several animal species in vivo, glutamate is a vasodilator (4, 6, 8, 9, 21, 27, 28) . The mechanisms underlying these vasoactive effects are unclear. Glutamate may, by increasing neuronal discharge activity, promote the neuronal production of vasorelaxant factors, including nitric oxide (NO) (6, 8, 9, 21) , and CO (1, 34) . CO and NO may play complementary roles in cerebral arteriolar diameter regulation. A recent study (18) , designed to analyze the interactions between CO and NO, demonstrated that NO was acting in a permissive way to allow CO-induced cerebral vasodilation in newborn pigs. These data, combined with those of Meng et al. (21) , suggest the possibility that the ability of NO synthase inhibitors to block dilation to glutamate could result from loss of the necessary permissive enabler for CO-induced dilation.
We investigated whether cerebral arterioles removed from the neuronal influences can directly respond to glutamate. To exclude neuronal influences, we conducted the experiments in isolated cerebral arterioles. In preparations of isolated arterioles, perivascular neurons (even if present in such small precapillary vessels in the brain in vivo) have been cut and severely damaged during arteriole removal from the brain parenchyma. Damaged neurons lose the ability to hold a membrane potential and to respond to stimulation, and, therefore, functional contribution of perivascular innervation to the responses of isolated arterioles is unlikely. Data are available on expression and functioning of glutamate receptors in isolated cerebral microvessels and cerebral endothelial cells of rat and pigs (16, 25, 26) , although some investigators did not detect such receptors (2, 23) . Recently, we detected NMDAtype glutamate receptors in endothelial cells from cerebral microvessels of newborn pigs by a competitive radioligand binding assay and by immunoblotting (25) . It has been shown that rat cerebral microvessels express ionotropic and metabotropic glutamate receptor subunits and that the effects of glutamate agonists in the modulation of blood-brain barrier function are mediated directly through the sites of action on cerebral microvessels (28) . Our present study shows that isolated cerebral arterioles respond to amino acid excitatory neurotransmitters, glutamate and a NMDA receptor agonist, cis-ACPD, by vasodilation. The dilator responses of pressurized cerebral arterioles to glutamate receptor stimulation are comparable with the responses to such potent vasodilators as bradykinin and isoproterenol. These data support the hypothesis that cerebral arterioles can be directly targeted by glutamate via a glutamate receptor-mediated mechanism.
Our data show that HO inhibition completely blocked vasodilation of isolated arterioles to glutamate and an NMDA receptor agonist, suggesting involvement of cerebrovascular-derived CO. In cerebral microvessels from newborn pigs, HO is highly expressed (17, 26) , and HO-directed CO production is stimulated by glutamate via ionotropic glutamate receptors, including NMDA-type receptor (27) . HO-2, the constitutive isoform of HO, is expressed in vascular endothelium of cerebral microvessels. Cultured cerebral microvascular endothelial cells respond to agonists of ionotropic glutamate receptors by increasing CO production (25) . Therefore, we hypothesized that an intact endothelium is essential for cerebral arteriolar dilation to excitatory amino acids. To investigate the role of the endothelium in the CO-mediated response to glutamate, we studied intact and endothelium-denuded cerebral arterioles. Functional denudation of arterioles was confirmed by the absence of dilation to bradykinin, an endothelium-dependent vasodilator in the cerebral circulation of newborn pigs in vivo (33) . We obtained dilation to glutamate only in isolated pressurized arterioles with an intact endothelium but not in endothelium-denuded arterioles. The loss of these responses was not due to generalized injury to the arteriole because isoproterenol, an endothelium-independent vasodilator, produced similar dilation after endothelial removal. Therefore, endothelial removal abolished the responses to glutamate, suggesting that CO released from the endothelium is important in vasodilation of cerebral arterioles to excitatory neurotransmitters.
In conclusion, our data suggest that cerebral arterioles from newborn pigs may directly respond to glutamatergic stimulation via a glutamate receptor-mediated mechanism. Endothelium-dependent vasodilator effects of glutamate in cerebral circulation involve CO as vascular-derived vasorelaxant factor.
